Dr. Reddy's Laboratories ...

NYSE: RDY · Real-Time Price · USD
14.12
-0.14 (-0.98%)
At close: Aug 14, 2025, 3:59 PM
14.00
-0.85%
After-hours: Aug 14, 2025, 05:16 PM EDT

Dr. Reddy's Laboratories Income Statement

Financials in INR. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
325.54B 279.16B 245.88B 214.39B 189.72B
Cost of Revenue
135.11B 115.56B 42.91B 100.55B 86.64B
Gross Profit
190.43B 163.61B 202.97B 113.84B 103.08B
Operating Income
71.84B 67.73B 96.28B 40.82B 36.06B
Interest Income
2.68B 2.28B 1.18B 965M 826M
Pretax Income
76.78B 71.87B 60.48B 32.3B 28.32B
Net Income
56.54B 55.68B 45.07B 23.57B 17.24B
Selling & General & Admin
93.87B 77.2B 105.93B 62.08B 54.56B
Research & Development
27.38B 22.87B 19.38B 17.48B 16.54B
Other Expenses
-2.67B -4.2B -7.7B -2.76B -982M
Operating Expenses
118.58B 95.88B 117.61B 76.8B 70.12B
Interest Expense
2.83B 1.71B 1.43B 958M 970M
Selling & Marketing Expenses
n/a n/a 59.47B n/a n/a
Cost & Expenses
253.69B 211.44B 160.52B 177.35B 156.76B
Income Tax Expense
19.54B 16.19B 15.41B 8.73B 9.18B
Shares Outstanding (Basic)
833.31M 833.54M 830.17M 829.41M 829.22M
Shares Outstanding (Diluted)
834.3M 833.54M 831.91M 831.69M 831.58M
EPS (Basic)
67.85 66.80 54.29 28.42 20.79
EPS (Diluted)
67.77 66.80 54.17 28.34 20.73
EBITDA
96.67B 88.42B 74.43B 47.74B 45.71B
EBIT
79.61B 73.58B 61.8B 33.26B 27.38B
Depreciation & Amortization
17.06B 14.84B 12.64B 11.82B 12.8B